You can buy or sell Prothena and other stocks, options, ETFs, and crypto commission-free!
Prothena Corporation plc Ordinary Shares, also called Prothena, is a late-stage clinical biotechnology company, which research, development and commercialization of therapies in the neuroscience and orphan categories. Its antibody-based product candidates target a potential indications including amyloidosis and Parkinson's disease. Read More The company was founded in December 1969 and is headquartered in Dublin, Ireland.
Dun Laoghaire, Dublin
52 Week High
52 Week Low
Expected Feb 11, After Hours